74:_9}]4Y~)P/KA8>@B-7<RLO9&:
SYSTEM PROCESSING...
74:_9}]4Y~)P/KA8>@B-7<RLO9&:
SYSTEM PROCESSING...
Posted: 2025-03-28 14:21:26 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-03-28 14:22:16 UTC
Verified By
Rollup News
Liquidia Corporation's NDA resubmission for YUTREPIA (treprostinil) inhalation powder has been accepted by the FDA. PDUFA goal date is May 24, 2025.